Pharmacological inhibition of BLT1 diminishes early abdominal aneurysm formation
- 28 December 2009
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 210 (1), 107-113
- https://doi.org/10.1016/j.atherosclerosis.2009.11.031
Abstract
No abstract availableKeywords
Funding Information
- NIH (S10RR022586)
This publication has 28 references indexed in Scilit:
- Expression of functional leukotriene B4 receptors on human airway smooth muscle cellsJournal of Allergy and Clinical Immunology, 2009
- Role of Leukotriene B4Receptors in the Development of Atherosclerosis: Potential MechanismsArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and AtherosclerosisNew England Journal of Medicine, 2004
- Aortic Dissection Precedes Formation of Aneurysms and Atherosclerosis in Angiotensin II-Infused, Apolipoprotein E-Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- BLT1 and BLT2: the leukotriene B4 receptorsProstaglandins, Leukotrienes & Essential Fatty Acids, 2003
- Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesisProceedings of the National Academy of Sciences, 2003
- Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4Nature Medicine, 2002
- Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Abdominal Aortic Aneurysms: Basic Mechanisms and Clinical ImplicationsCurrent Problems in Surgery, 2002
- Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient miceJCI Insight, 2000